What's new?

2nd Workshop on the Characterisation of Heparin Products

(02/09/08) This workshop was jointly organised by the EDQM, the NIBSC and the USP to discuss the characterisation and quality control of heparins.  The 'Summary of Workshop Sessions' is now available to download. More information.....

Recruitment

Closing date: 7 October

Vacancy Notice N° e74/2008
Post of Head of the European Pharmacopoeia Department
Under the authority of the Director of EDQM, the post-holder provides leadership to and ensures efficient management of the European Pharmacopoeia Department (EPD) in compliance with regulatory mandates and provisions in force as well as with Council of Europe values and priorities. More information...

Vacancy Notice N° e75/2008
Post of Head of the Laboratory Department
Under the authority of the Director of EDQM, the post-holder provides leadership to and ensures efficient management of the EDQM Laboratory Department (DLab) in compliance with regulatory mandates and provisions in force as well as with Council of Europe values and priorities. More information...

European Pharmacopoeia Commission

(21/07/08) The Commission held its 131st Session on 24-25th June, available are the list of decisions and the modifications of the work programme. More information...

NEW: Revised heparin monographs

Implementation date: 1st August 2008

(08/07/08) The following revised heparin monographs were adopted by the European Pharmacopoeia Commission at its 131st session on 25 June 2008, using the rapid implementation procedure. The implementation date is 1 August 2008. More information....

Revised heparin sodium monograph
Revised heparin calcium monograph

Potentially genotoxic impurities

(01/07/08) Policy paper for dealing with potentially genotoxic impurities to be applied during elaboration and revision of monographs. More information....

13th Annual Meeting of OMCL Network

(20/06/08) The EDQM held its 13th Annual Meeting of the Official Medicines Control Laboratory (OMCL) Network in Strasbourg from 2 to 6 June 2008. This annual conference was organised at the new headquarters of the EDQM and was attended by over 200 participants.  More Information... 

EDQM participates in an international meeting on heparins

(13/05/08) The EDQM participated in a recent meeting organised by the United States Food and Drug Administration (FDA) to state the European Pharmacopoeia’s position and to share its experience on the current issues concerning the quality of heparins following adverse effects reported earlier this year. More information....